Nokia Falls 7.4% as Investors Rotate to Defensives

The move also stands out against the broader Nordic set in North America, where investors appeared more willing to pay for companies with steadier cash flows and clearer near-term earnings visibility. AstraZeneca’s gain reflects that preference: in a risk-off pocket of the market, pharmaceuticals and other defensive names tend to attract capital while telecom infrastructure names are asked to prove that revenue momentum can persist.

For Nokia, the pressure comes even as management has been highlighting progress in areas tied to next-generation networks. Recent company disclosures pointed to the first AI-RAN call in a live operator network with T-Mobile and Nvidia, part of Nokia’s push to position itself as a beneficiary of AI-driven network spending. But the market is looking past the technology narrative and focusing instead on how quickly those initiatives translate into margins and free cash flow.

Technically, the stock’s retreat leaves it below both its 50-day and 200-day moving averages, with RSI readings indicating the shares have lost momentum after a volatile rebound earlier in the year. That combination often reinforces short-term selling as portfolio managers trim exposure rather than wait for a clearer catalyst.

The message for investors is that Nokia remains a stock priced for proof, not promise. Bulls can still argue that carrier modernization, optical and core-network demand, and AI infrastructure could support a rerating if operating leverage improves. Bears will counter that any disappointment on timing, pricing or mix could keep the shares under pressure, especially if global investors continue favoring defensive sectors and higher-visibility earnings stories.

What matters next is whether Nokia can turn its AI-network positioning into hard numbers in coming updates. Until then, the stock is likely to trade as a test of whether telecom equipment can join the broader market’s winners — or remain stuck in the laggard bucket.